BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer Biotech Investing
BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+ for Breast Cancer Biotech Investing
Stoke Therapeutics Presents Two-Year Natural History Data from Patients with Autosomal Dominant Optic Atrophy Genetics Investing
Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025 Life Science Investing
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome Genetics Investing
Stoke Therapeutics and Biogen Present New Data at the 54th Child Neurology Society Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome Genetics Investing
